Xing Lianping, Boyce Brendan F
Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, NY, USA.
Biochem Biophys Res Commun. 2005 Mar 18;328(3):709-20. doi: 10.1016/j.bbrc.2004.11.072.
In postnatal life, the skeleton undergoes continuous remodeling in which osteoclasts resorb aged or damaged bone, leaving space for osteoblasts to make new bone. The balance of proliferation, differentiation, and apoptosis of bone cells determines the size of osteoclast or osteoblast populations at any given time. Bone cells constantly receive signals from adjacent cells, hormones, and bone matrix that regulate their proliferation, activity, and survival. Thus, the amount of bone and its microarchitecture before and after the menopause or following therapeutic intervention with drugs, such as sex hormones, glucocorticoids, parathyroid hormone, and bisphosphonates, is determined in part by effects of these on survival of osteoclasts, osteoblasts, and osteocytes. Understanding the mechanisms and regulation of bone cell apoptosis will enhance our knowledge of bone cell function and help us to develop better therapeutics for the management of osteoporosis and other bone diseases.
在出生后的生命过程中,骨骼经历持续的重塑,其中破骨细胞吸收老化或受损的骨骼,为成骨细胞生成新骨留出空间。骨细胞增殖、分化和凋亡的平衡决定了在任何给定时间破骨细胞或成骨细胞群体的大小。骨细胞不断接收来自相邻细胞、激素和骨基质的信号,这些信号调节它们的增殖、活性和存活。因此,绝经前后或使用性激素、糖皮质激素、甲状旁腺激素和双膦酸盐等药物进行治疗干预后骨骼的数量及其微观结构,部分取决于这些药物对破骨细胞、成骨细胞和骨细胞存活的影响。了解骨细胞凋亡的机制和调节将增进我们对骨细胞功能的认识,并帮助我们开发更好的治疗方法来管理骨质疏松症和其他骨疾病。